Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Arjuna's High Efficacy Ashwagandha Extract Gets Health Canada Endorsement


News provided by

Arjuna Natural Ltd.

Mar 25, 2025, 07:00 ET

Share this article

Share toX

Share this article

Share toX

New recognition greenlights Arjuna's Shoden® health claims for reducing stress and aiding sleep

KOCHI, India, March 25, 2025 /PRNewswire/ -- Nutraceutical pioneers Arjuna Natural Pvt. Ltd., announces that its Shoden® ashwagandha extract has been approved as a Natural Health Product (NHP) by Health Canada. This official endorsement affirms the botanical composition's safety and efficacy, and validates it as a trusted, high-quality product in the Canadian natural health market.

Continue Reading
Arjuna’s High Efficacy Ashwagandha Extract Gets Health Canada Endorsement
Arjuna’s High Efficacy Ashwagandha Extract Gets Health Canada Endorsement

A Natural Product Number from Health Canada is globally regarded as the gold standard in natural health-product certification. To attain such, a product must undergo a rigorous pre-market review process involving testing the ingredient for purity and potency and evaluating published scientific research and clinical studies on the product. These measures ensure that natural dietary supplements meet stringent quality standards before they are licensed.

Shoden® is a highly bioactive extract of ashwagandha (Withania somnifera), distinguished by its standardization to more than 35% withanolide glycosides (as measured by HPLC), the key active compounds in the adaptogenic. Also called Indian Ginseng, the botanical dynamo is noted for its antioxidant, anti-inflammatory properties and is considered a 'rasayana' a rejuvenating herb in traditional Ayurvedic medicine due to its studied capacity to enhance overall resilience and vitality.

"Our potent ashwagandha extract of the whole plant is derived from carefully chosen and validated sources using a proprietary extraction process," says Benny Antony, PhD, Joint Managing Director for Arjuna Natural. for Arjuna Natural. "This ensures exceptional absorption and maximum utilization of the full spectrum of withanolide compounds, even at an unusually low dose of 60-120mg. Shoden® holds a string of 23 patents for its unique formulation and manufacturing methods."

Approved to wear health benefits label

"Troublingly, there are numerous unregulated ashwagandha extracts on the market that are failing to deliver what they promise," asserts Antony. "This recognition by Health Canada confirms Shoden® as a reliable, scientifically backed source of the extract that delivers the distinct wellness benefits of ashwagandha. It underscores Arjuna Natural's commitment to supplying regulatory compliant, high-quality ingredients that consumers in Canada and internationally can trust."

Earning this new seal empowers Arjuna to make authorized health claims for its prized ashwagandha extract, potentially opening new doors. It also will allow supplement manufacturers to make label recommendations pertaining to Shoden®'s specific health benefits on their end products.

These include:

  • Helps improve sleep onset, duration, and quality when used over time.
  • Helps increase resistance to stress and reduce symptoms of mild anxiety in individuals with a history of chronic stress.
  • Helps reduce the symptoms of stress when used over time.
  • May be used in herbal medicine as an adaptogen to help increase energy and resistance to stress over time (e.g., in case of mental and physical fatigue related to stress).
  • Helps promote healthy testosterone production in males.
  • Helps reduce cortisol, a biomarker of physical stress, when used over time.

23 patents and 11 clinical studies strong

Shoden® boasts the backing of no fewer than 11 clinical studies and 4 animal studies, supporting its positive role in alleviating stress and anxiety and improving sleep quality, even at low doses. The studies have linked its stress-relieving effects to its ability to regulate the hypothalamus-pituitary-adrenal axis, reducing the stress hormone cortisol and increasing GABA neurotransmitters for relaxation. Another clinical study highlights its immunomodulating benefits, demonstrating natural improvements in immune cell markers, including natural killer and T-cell activity, all suggesting potential for reducing infection risks and boosting immunity.

Importantly, a pharmacokinetics evaluation of the highly standardized and purified Shoden® formulation in blood serum samples revealed exceptional bioavailability of the beneficial withanolides. Moreover, acute and subchronic toxicity studies on animals have proven excellent safety credentials.

"We are excited to bring Shoden® to the Canadian nutraceutical space and look forward to collaborating with researchers and product developers, not only in Canada but internationally, helping them to create innovative solutions for stress management and overall well-being," adds Antony. "The US, and countries in Europe and Asia view Health Canada approval as a highly reliable benchmark for quality, which will fast-track Shoden®'s expansion into those markets."

Shoden®­­­­­­­­­­­­ is available in three doses and in multiple supplement formats, including pills, capsules, and powders. With the rising popularity of functional foods, its low -dosing capabilities allow it to be integrated seamlessly into food and beverage applications, including soft drinks, energy shots and other sports nutritional products.

About Arjuna Natural 

For more than a quarter of a century Arjuna Natural has been India's leading manufacturer of standardized spice and botanical extracts for food supplement industries. Established in 1989, the company is, dedicated to eco-friendly and sustainable practices and has grown rapidly, serving customers in 70 countries. Arjuna has an advanced research facility that works in collaboration with international universities on phytochemistry, pharmacokinetics, formulation, development, and pre-clinical and toxicity research. Arjuna Natural's facilities comply with the highest world standards, are GMP-certified, and have ISO, NSF, Star-K kosher, and halal certification.

For further information, please contact:

Company contact                                                                             
Arjuna Natural Pvt                                                                          
Benny Antony, PhD                                                                         
Joint Managing Director                                                               
Email: [email protected]                                                                 
Website: www.arjunanatural.com                                           
Twitter: @ArjunaExtracts                                                             

Press Contact:
NutriPR
Liat Simha
Tel: +972-9-9742893
E-mail: [email protected] 
Website: www.nutripr.com

Photo: https://mma.prnewswire.com/media/2649393/Arjuna_Natural.jpg

SOURCE Arjuna Natural Ltd.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Enhanced Bioavailability in Shoden® Ashwagandha Linked to Withanolide Glycosides

Enhanced Bioavailability in Shoden® Ashwagandha Linked to Withanolide Glycosides

A new clinical study identified withanolide glycosides as the key drivers of superior bioavailability in ashwagandha (Withania somnifera) extracts....

Somin-On™ Ashwagandha Improves Memory in Adults with Mild Cognitive Impairment

Somin-On™ Ashwagandha Improves Memory in Adults with Mild Cognitive Impairment

A new clinical study of Somin-On™, an ashwagandha (Withania somnifera) withanolide extract standardized to Sominone, highlights its potential for...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Supplementary Medicine

Supplementary Medicine

Food & Beverages

Food & Beverages

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.